Targeting Visceral Fat Visceral fat wraps around internal organs and presents greater health risks than subcutaneous fat
BPC-157 enhances the activity of natural growth factors in the body that promote healing
Microdosing starts at doses below the lowest commercially available starting dose and is titrated slowly to achieve neuromodulatory and metabolic effects without the full appetite suppression or side effects of standard dosing
Appl Microbiol Biotechnol 64 : 625-635
(A and B) Immunoblotting assays showing shCD36 reverses BRD4 and AR degradation by SIM1-Me (A) and ARV-110 (B), respectively, in LNCaP cells under indicated conditions.(E and F) Immunoblotting assays showing increasing expression of HA-tagged CD36 protein in shCD36-LNCaP cells restores BRD4 and AR degradation by SIM1-Me (E) and ARV-110 (F), respectively, in LNCaP cells under indicated conditions.(GJ) Viability of shEEA1+Vec-, shLuc+Vec-, shCD36+Vec-, shCD36+CD36-LNCaP cells determined by MTT assays after incubation with increasing concentrations of SIM1-Me (G), ARV-110 (H), MZ1 (I), or paclitaxel (J)
